StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)

Close on Nov 18, 2026Market cap $104.20MP/E –Yield –

NovaBridge Biosciences cash

Cash and short-term investments held at the end of each period.

NovaBridge Biosciences's cash was CN¥2.28B at Dec 31, 2023. For fiscal 2023 it was CN¥2.28B, down 33.8% from the year before. The highest annual figure on record is CN¥4.79B in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2023Dec 31, 2023CN¥2.28B-33.8%
FY2022Dec 31, 2022CN¥3.45B-19.3%
FY2021Dec 31, 2021CN¥4.28B-10.7%
FY2020Dec 31, 2020CN¥4.79B+291.0%
FY2019Dec 31, 2019CN¥1.23B-27.1%
FY2018Dec 31, 2018CN¥1.68B+307.3%
FY2017Dec 31, 2017CN¥412.71M+544.0%
FY2016Dec 31, 2016CN¥64.08M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023CN¥2.28B-47.5%
Q4 FY2022Dec 31, 2022CN¥3.45B-28.0%
Q2 FY2022Jun 30, 2022CN¥3.92B+31.2%
Q4 FY2021Dec 31, 2021CN¥4.28B+249.0%
Q2 FY2021Jun 30, 2021CN¥4.35B+239.6%
Q4 FY2020Dec 31, 2020CN¥4.79B+185.0%
Q3 FY2020Sep 30, 2020CN¥2.99B+624.1%
Q4 FY2019Dec 31, 2019CN¥1.23B+1812.1%
Q3 FY2019Sep 30, 2019CN¥1.28B–
Q4 FY2018Dec 31, 2018CN¥1.68B–
Q4 FY2017Dec 31, 2017CN¥412.71M–
Q4 FY2016Dec 31, 2016CN¥64.08M–

More NovaBridge Biosciences figures

See a number that looks wrong?